Meet AmoyDx at ELCC 2018 in Switzerland for NSCLC Molecular Testing
Date:2018-04-04Source: AmoyDx
Amoy Diagnostics will be exhibiting at the ELCC 2018 in Geneva, Switzerland. Welcome to visit us. The exhibition details are below.
Exhibition Place: Geneva
Exhibition Dates: April 11-14, 2018
Booth Number: No. 22 (Hall 1)
Important Leads:
◊ Super-ARMS EGFR, Full Coverage (42 mutations) & High Sensitivity & Tissue/Plasma Specimen
◊ ROS1 Testing, 1st Companion Diagnostics Kit of Xalkori, achieved PMDA approval in Japan
Recommend
AmoyDx® PD-L1 (E1L3N) assay gained the priority recommendation from Chinese expert consensus
21 /02
AmoyDx has successfully held the 2023 Distributors Annual Meeting at the headquarter in Xiamen, China, on January 22-23, 2024
06 /02
Highlights of China International Import Expo (CIIE) 2023 - Amoy Diagnostics Announced Multiple Collaborations with AstraZeneca and Pfizer
13 /11
AmoyDx® Microsatellite Instability (MSI) Detection Kit Received NMPA Approval for Pan-Tumor Immunotherapy Companion Diagnostics
03 /11
AmoyDx Collaborates with AstraZeneca to Develop a HER2 Companion Diagnostic for Lung Cancer in China
15 /08